Table 3.
Treatment | Dosage | Days of treatment | Number of infected dogsa, b | No. dogs positive for adult heartworm AGc | No. dogs positive for MF | ||
---|---|---|---|---|---|---|---|
Day 151 (181 days PI) |
Day 178 (208 days PI) | Day 151 (181 days PI) |
Day 178 (208 days PI) | ||||
Negative control | NA | 0 | 6 of 6 | 6 of 6 | 6 of 6 | 4 of 6 | 6 of 6 |
ProHeart 12 | 0.5 mg/kg moxidectind | 0 | 0 of 5 | 0 of 5 | 0 of 5 | 0 of 5 | 0 of 5 |
Heartgard Plus |
Min. of 6 µg/kg ivermectine |
0, 30, 60, 90, 120, 150 | 6 of 6 | 5 of 6f | 6 of 6g | 5 of 6 | 6 of 6 |
Interceptor Plus |
Min. of 0.5 mg/kg milbemycin oximeh |
0, 30, 60, 90, 120, 150 | 6 of 6 | 6 of 6 | 6 of 6 | 6 of 6 | 6 of 6 |
aEach dog was inoculated with 50 D. immitis third-stage larvae (JYD-34 strain) on day −30
bAll dogs were necropsied for recovery of adult D. immitis on day 185 (215 days PI; 35 days after the last treatment with Heartgard® Plus and Interceptor® Plus)
cDiroCHEK
dProHeart 12 (moxidectin extended-release injectable suspension) administered according to commercial label directions which resulted in a point administration of 0.5 mg/kg of moxidectin to each dog. One dog in the ProHeart 12 group was euthanized on day 90 due to an abnormal health event unrelated to drug treatment
eHeartgard Plus (ivermectin + pyrantel) administered according to commercial label directions which resulted in administration of from 6.6 to 11.2 µg/kg of ivermectin
fTwo of six dogs positive only after heat treatment; positive on both DiroCHEK and Snap4DX Plus
gTwo of six dogs positive only after heat treatment; positive on both DiroCHEK and Snap4DX Plus
hInterceptor Plus (milbemycin oxime + praziquantel) administered according to commercial label directions which resulted in administration of from 0.52 to 1.0 mg/kg milbemycin oxime